Skip to main
TFX

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 29%
Hold 57%
Sell 0%
Strong Sell 0%

Bulls say

Teleflex is expected to experience strong organic revenue growth, margin expansion, and potential accretive acquisitions in the coming years, leading to a positive outlook for its stock. The recent divestitures of non-core businesses and debt reduction also suggest the company is taking steps to optimize its operations and improve its financials. With a solid portfolio and a plan to spin-off or sell certain business lines, Teleflex has the potential for significant upside if all goes according to plan, but there are risks and uncertainties that could impact its performance. Overall, TFX is positioned for long-term success and has the potential to achieve mid-single digit organic growth and increased earnings power.

Bears say

Teleflex is a company facing challenges in its Interventional cardiology and UroLift businesses, which are expected to continue to impact its overall revenue and earnings growth significantly in the next few years. The recent divestitures by the company will also result in lower revenue and earnings expectations. However, potential upside risks include a faster-than-expected recovery in its UroLift business and successful execution of its cost reduction efforts.

Teleflex (TFX) has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 29% recommend Buy, 57% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 7 analysts, Teleflex (TFX) has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $139, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $139, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.